Adjuvant Directed Immune Specificity at the Epitope Level: Implications for Vaccine Development a Model Study Using Semliki Forest Virus Infection of Mice
The objective of vaccination is to provide acquired protective immunity against invasive pathogens like viruses, bacteria, protozoa etc. For a number of them there is a vaccine available (against mumps, rubella, poliomyelitis, diphtheria, measles, hepatitis B, tuberculosis...) that shows a variable degree of efficacy and in minor instances unwanted side effects. Socioeconomic status of the population and immunological state of the individual (different for newborns, toddlers, elderly, immunosuppressed) influence the outcome of vaccination to a high extent. Until now no vaccine has been developed for a variety of diseases, malaria and human immunodeficiency virus (HIV) being important examples, and for many others (pneumococcus) an improved version of the current vaccine remains to be prepared.
KeywordsHuman Immunodeficiency Virus Cell Epitope Peptide Vaccine Semliki Forest Virus Adjuvant Activity
Unable to display preview. Download preview PDF.
- Braathen, L.R., Bjercke, S. and Thorsby, E., 1984, The antigen-presenting function of human Langerhans cells. Immunobiol., 168: 301.Google Scholar
- Cease, K.B., Margalit, H., Cornette, J.L., Putney, S.D., Robey, W.G., Ouyang, C., Streicher, H.Z., Fischinger, P.J., Gallo, R.C., Delisi, C. and Berzofsky, J.A., 1987, Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide, Proc. Natl. Acad. Sci. USA, 84: 4249.PubMedCrossRefGoogle Scholar
- Fernández, I.M., 1996, Diversity of the humoral response against peptide and anti-idiotypic vaccines in the Semliki Forest virus model, Academic Thesis. Utrecht..Google Scholar
- Langeveld, J.P.M., Casal, J.I., Osterhaus, A.D.M.E., Cortés, E., Swart, R. De, Vela, C., Dalsgaard, K., Puijk, W.C., Schaaper, W.M.M. and Meloen, R.H., 1994, First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs, J. Virol., 68: 4506.PubMedGoogle Scholar
- Levely, M.E., Mitchell, M.A. and Nicholas, J.A., 1990, Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T: B chimeras): preferential stimulation of unique T-and B-cell specificities is influenced by immunogen configuration, Cell. Immunol., 125: 65.PubMedCrossRefGoogle Scholar
- Niman, H.L., Houghten, R.A., Walker, L.E., Reisfeld, R.A.,. Wilson, I.A., Hogle, J.M. and Lerner, R.A., 1983, Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition, Proc. Natl. Acad. Sci. USA, 80: 4949.PubMedCrossRefGoogle Scholar
- Snijders, A., Benaissa-Trouw, B.J., Oosterlaken, T.A.M., Puijk, W.C., Posthumus, W.P.A., Meloen, R.H., Boere, W.A., Oosting, J.D., Kraaijeveld, C.A. and Snippe, H., 1991, Identification of linear epitopes on Semliki Forest virus and their efficacy as synthetic peptide vaccine, J. Gen. Virology, 72: 557.CrossRefGoogle Scholar
- Snijders, A., 1992, Vaccine efficacy of synthetic peptides. A model study using Semliki Forest virus infection of mice. Academic Thesis. Utrecht.Google Scholar
- Steward-Tull, D.E.S., ed., 1983. in: “Biology of Microbacteria” vol. 2, Academic Press, London.Google Scholar
- Zigterman, G.J.W.J., Snippe, H., Jansze, M. and Wiüers, J.M.N., 1988, Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response. II. Mode of action. Chapter 3, Academic Thesis, Utrecht.Google Scholar